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One of the complexes formed by the hematopoietic transcription factor Gata1 is a complex with the Ldb1
(LIM domain-binding protein 1) and Tal1 proteins. It is known to be important for the development and
differentiation of the erythroid cell lineage and is thought to be implicated in long-range interactions. Here, the
dynamics of the composition of the complex—in particular, the binding of the negative regulators Eto2 and
Mtgr1—are studied, in the context of their genome-wide targets. This shows that the complex acts almost
exclusively as an activator, binding a very specific combination of sequences, with a positioning relative to
transcription start site, depending on the type of the core promoter. The activation is accompanied by a net
decrease in the relative binding of Eto2 and Mtgr1. A Chromosome Conformation Capture sequencing (3C-seq)
assay also shows that the binding of the Ldb1 complex marks genomic interaction sites in vivo. This establishes
the Ldb1 complex as a positive regulator of the final steps of erythroid differentiation that acts through the
shedding of negative regulators and the active interaction between regulatory sequences.
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Hematopoietic stem cell differentiation to the erythroid
lineage involves coordinated changes in transcription,
often by functionally conserved genes such as Gata2,
Tal1, Lmo2, Gata1, and Runx1 (Cantor and Orkin 2001).
These factors can form different complexes, but also in-
teract with each other in a transcription complex known
as the Ldb1 complex. The nuclear protein Ldb1 (LIM
domain-binding protein 1) has no DNA-binding or enzy-
matic activities. Its main functional domains are the LIM
interaction domain (LID) in the C-terminal part of the
protein, interacting with LIM-only protein (LMO) and
LIM homeodomain (LIM-HD) factors; the dimerization
domain in the N-terminal part of the protein; the Ldb1/
Chip conserved domain (LCCD) domain, which interacts
with the Ssbp proteins; and the NLS (nuclear localization
signal) (Jurata and Gill 1997; Breen et al. 1998; Matthews
and Visvader 2003; Xu et al. 2007). Studies in Xenopus
have shown that LID and dimerization domains are
important for its function in vivo (Breen et al. 1998).
In murine erythroid cells, Ldb1 was originally described
as part of a complex composed of the transcription factors
Tal1, Gata1, and E2A, and the non-DNA-binding Lmo2
functions as a bridging molecule, together with the assis-
tance of Ldb1, between the DNA-binding factors (Wadman
et al. 1997). The complex binds to a GATA–E-box motif
and is thought to bind to a number of genes that are up-
regulated in erythroid differentiation (Brand et al. 2004),
including the b-globin locus control region (LCR) and
the b-globin gene promoter, where it is thought to be
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important for looping of the LCR to the promoter (Song
et al. 2007).
A recent proteomics study (Meier et al. 2006) in mouse
erythroleukaemic (MEL) cells expanded the number of
proteins present in the Ldb1/Lmo2/Tal1/E2A/Gata-1
complex to include HEB, Lmo4, and Lyl1 (closely related
to Tal1), and a number of proteins (Ssbp1–4) important for
the stability of the Ldb1 protein (Xu et al. 2007). In the
proerythroblast-proliferating state, this complex was found
to interact with another complex consisting of Gata1/Tal1/
E47/HEB/Mtgr1/Eto2 as well as with the cell cycle regula-
tor Cdk9 and E2-2, with the equilibrium favoring the larger
multiprotein complex (Meier et al. 2006). Upon differenti-
ation and cessation of proliferation of the MEL cells, Cdk9
and E2-2 are no longer part of the larger complex, which
may favor the dissociation into the two smaller complexes
and allow the dimerization of the smaller complex to form
loops in the chromatin. The process coincides with a de-
crease in the level of the suppressive factors Eto2 and
Mtgr1 (Davis et al. 2003; Schuh et al. 2005), and an increase
in the level of another Lim-only factor, Lmo4 (Grutz et al.
1998; Kenny et al. 1998).
Absence of Ldb1 results in early death of the embryo
between embryonic day 9.5 (E9.5) and E10.5 with a series
of developmental defects, including truncation of the
anterior head structure, no heart formation, axis dupli-
cation, and absence of hematopoiesis (Mukhopadhyay
et al. 2003; M Mylona, JC Bryne, W van IJcken, and F
Grosveld, unpubl.). The latter defect resembles the knock-
out phenotypes of the hematopoietic transcription factors
Gata2/Gata1, Lmo2, and Tal1 (Warren et al. 1994; Robb
et al. 1995; Shivdasani et al. 1995; Porcher et al. 1996).
The early phenotype of these knockouts is explained by
the observation that Ldb1, Cdk9, E2A, Lmo2, Gata1, and
Eto2 are expressed in the PSp/AGM region of the 9.5-d-
post-coitum (dpc) mouse embryo that will later give rise
to hematopoietic stem cells (Meier et al. 2006). Differ-
entiation of embryonic stem cells in vitro shows that
the number of blast colony-forming cells, the in vitro
equivalent of the hemangioblast, is severely reduced,
and they have lost the potential to grow and differenti-
ate (M Mylona, JC Bryne, W van IJcken, and F Grosveld,
unpubl.).
Although a number of target genes of the Ldb1 complex
have been described (Anguita et al. 2004; Brand et al. 2004;
Lahlil et al. 2004; Tripic et al. 2009) its targets are largely
unknown, although a subset of these were reported very
recently (Wilson et al. 2009). Here, we report a dynamic
picture of the last steps of erythroid differentiation in
a model system, through the analysis of the target genes
of the Ldb1 complex, by integrating its genome-wide
target-binding sequences with the changing gene expres-
sion profiles of C88 MEL cells before and after differen-
tiation. This analysis shows a changing binding site
profile for the Ldb1 complex during differentiation, for
the first time reveals the differences between different
classes of core promoters with respect to the preferred
relative position of activating complexes, and shows that
binding sites of the Ldb1 complex mark positions of long-
range interactions.
Results
Analysis of binding sites
The basic scheme (Fig. 1A) for the analysis of the Ldb1
complex entails the introduction of a tag into a number of
the transcription factors that have been identified pre-
viously (Meier et al. 2006). The biotinylation tag, which is
biotinylated by the bacterial biotin ligase BirA (Cronan
and Reed 2000; de Boer et al. 2003), and the viral V5 tag
(Southern et al. 1991) are both insensitive to formalde-
hyde fixation and, in particular, the biotin tag is excellent
in chromatin immunoprecipitations (ChIPs) followed by
sequencing (ChIP-seq) (e.g., see Ku et al. 2008; Kolodziej
et al. 2009; Soler et al. 2009). The tagged genes are sub-
sequently introduced by stable transfection into C88
MEL cells, and only clones that show expression levels
lower than or similar to the endogenous factors (both
before and after differentiation of the C88 cells) are used
for further analysis to avoid possible phenotypic or other
changes due to the overexpression of one of the factors.
None of the transfected cell lines showed an aberrant
phenotype, and all were fully capable of differentiation
(data not shown). Moreover, the tagged proteins are reg-
ulated the same as the endogenous factors (Supplemental
Fig. 1). After a particular cell line was grown, the ChIP-seq
protocol was carried out as described (Soler et al. 2009) for
Ldb1, Gata1, Tal1 (Scl), Mtgr1, and Eto2. Typically, the
ChIPs of known binding sites show an enrichment of 10-
fold to 30-fold for either V5 or the biotin tag, whereas
sequences that do not bind the complex are not enriched
(Supplemental Fig. 2A). The precipitated material was
sequenced using the standard Illumina/Solexa protocol,
the sequences were mapped back to the genome using
the Eland software (Illumina), and peaks were visualized
using in-house-developed software (Solex) (Soler et al.
2009; HWJ Rijkers, unpubl.) or the ChIP-seq Visualization
Browser based on G-Browse (http://tracc.genereg.net). Be-
tween 10 and 60 million sequences were mapped back to
the genome for each of the factors. For example, at the com-
parable noise level (maximal empirical P-value of 5%), we
were able to detect 5205 Gata1-binding sites, 4173 Tal1-
binding sites, and 4982 Ldb1 sites in the induced state in
the entire genome (Fig. 1B). The number of actual binding
sites is certainly higher than that, as confirmed by a much
higher than random co-occurrence of these factors at sites
that fall below the 10% false discovery rate (FDR) thresh-
old. We validated the MEL cell data by carrying out the
same analysis in primary erythroid cells derived from
mouse E13.5 fetal liver, which shows an overlap of 83%
of the binding sites (Supplemental Fig. 3). The significance
of the data is immediately apparent when the transcription
factor-binding sites are comparedwith the control ChIP-seq
(Supplemental Fig. 2B). The analysis of the correlation of
binding sites between the factors shows that the large
majority of strong Ldb1-binding locations after differentia-
tion is also bound by Gata1 and Tal1, establishing the Ldb1
complex as the most common way of Ldb1-mediated reg-
ulation of terminal erythropoiesis (Figs. 1B, 5 [below]). On
the other hand, as expected, each of the factors can form
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complexes with factors other than the ones examined here
(Meier et al. 2006). For example, a subset of strong Gata1
sites shows little or no concomitant Tal1 and Ldb1 binding,
revealing the existence and positions of different types of
Gata1 complexes in the same cell system. Indeed, Gata1
is known to form a number of complexes without Tal1 or
the other members of the Ldb1 complex (Hong et al. 2005;
Rodriguez et al. 2005). However, even between the dif-
ferentmembers of the complete complex there are a num-
ber of different target sites bound by smaller complexes.
For example, the3.5-kb enhancer of theGata1 gene binds
the entire complex (Fig. 2), whereas the regulatory se-
quence of theCdh23 gene binds an Ldb1 complex without
Eto2, while the Casp12 gene binds an Eto2 complex but
not Ldb1.
The list of binding sites contains many of the known
target genes (Wilson et al. 2009), but alsomanymore novel
ones. In a number of cases, however, it is not clear what the
target gene is that may be regulated by the Ldb1 complex;
in particular, in those situations where binding sites are
found at a large distance from any gene (see below).
Expression analysis to identify target genes
Two experiments were carried out in order to identify
genome-wide the target genes of the Ldb1 complex. First,
the binding sites of the complex were also determined after
differentiation of the cells, and the gene expression patterns
were determined before and after differentiation. The cells
used above were differentiated, and the binding sites of the
factors were determined as above (http://tracc.genereg.net/
download). Strikingly, most binding sites were still binding
the same complexes, but the ratio of binding of the dif-
ferent factors was changed. Most importantly, the number
of binding sites and the peak height of the suppressor fac-
tors Eto2 and Mtgr1 decreased after differentiation relative
to the other factors, indicating that the Ldb1 complex
changes toward an activating state during differentiation.
Figure 1. Analysis of transcription factor-binding sites by ChIP-seq using Solexa Genome Analyzer II. (A) Description of the work flow
used for transcription factor analysis. (B) Numbers of different complexes of the five measured factors, estimated using conservative
criteria (empirical P-value of 0.05 on the experiment with the weakest signal). The factors were considered part of the same complex if
the distance between centers of their binding peaks were within the resolution of the method (200 bp).
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Figure 3 shows examples of the binding sites of a number of
target genes before and after differentiation.
All of these genes—Gypa (glycophorin A), Epb4.2 (Band
4.2), Alas2, and Slc22a4—are induced late during erythroid
differentiation and show a difference in the ratio of the
binding of the different components of the Ldb1 complex.
In particular, the level of the negative regulators Eto2 and
Mtgr1 (Davis et al. 2003) decreases during differentiation
(Meier et al. 2006), whereas levels of Ldb1 and Tal1 in-
crease, which is reflected in a change in the relative ratio of
Eto2/Mtgr1 to Ldb1, or Tal1 binding to the regulatory se-
quences of these genes (Fig. 3E,F). This observation is sup-
ported by the genome-wide data analysis; at the same
stringency threshold (empirical P-value), there is a signifi-
cant drop in the Eto2- and Mtgr1-level content of Ldb1
complexes upon the induction of differentiation.
We next determined the changes in gene expression
pattern before and after differentiation by microarrays to
allow the identification of target genes of the Ldb1 com-
plex (Fig. 4; Supplemental Table 1; Supplemental Fig. 4).
This showed that many genes in the different pathways—
such as heme biosynthesis, cell cycle, apoptosis, and gas
transport—that are active in terminal erythroid differen-
tiation are target genes of the Ldb1 complex (e.g., see
Supplemental Table 2). This suggests that the function of
Eto2/Mtgr1 is to suppress target genes before differentia-
tion. This is confirmed by knocking down Eto2, which
shows that direct targets of the complex are derepressed in
bothMEL cells and primary erythroid cells (Supplemental
Fig. 5) without differentiation of the cells.
Motif analysis of transcription factor-binding sites
It is clear that the top of any of the peaks of binding sites
points directly at the recognition sequence of the binding
site. This provides a consensus sequence of the binding
sites as they are used in vivo. The Gata1 site strongly
matches the previously reported consensus WGATAR
(Supplemental Fig. 6), and is much better-defined than,
e.g., DNA SELEX-derived Gata1 profiles (e.g., MA0035
from JASPAR database) (Bryne et al. 2008). The Tal1-
binding sites give a different picture: While the published
E-box motif consensus is CANNTG (Murre et al. 1991),
our motif discovery on the bound sites using MEME
(Bailey et al. 2009) revealed a preference for TG dinucle-
otide upstream of WGATAR, with a preferred consensus
(C)TGN7–8WGATAR. Within the first 1284 top sites co-
occupied by Gata1 and Tal1, 1045 (81%) show the pres-
ence of a TG dinucleotide 7–8 bases upstream of the
WGATAR motif (TGN7–8WGATAR), among which 671
sites contain a C upstream of the TG (CTGN7–8WGATAR).
The remaining 239 sites show an overrepresentation of
E-box motif CWGCTG (with a positional overrepresen-
tation on the 59 side of the GATA sequence) (Supplemen-
tal Fig. 6). The separation of Gata1-binding sequences
into those that bind Tal1 and those that do not, followed
by de novo motif discovery on each set, revealed that this
upstream element is strongly overrepresented in Tal1-
positive sites only (Supplemental Fig. 6).
The other surprising observation is that, often, more
than one consensus binding site is observed at any given
position. For example, one of the binding sites of the
Epb4.2 (Band 4.2) gene shows a double site (Supplemental
Fig. 7). Multiple sites may serve to increase the efficiency
of complex recruitment and/or may allow simultaneous
interactions with several distant sites.
Correlation of transcription factor-binding sites
with gene expression and promoter type
The genes that were up-regulated or down-regulated were
subsequently compared with the positions of experimen-
tally detected binding sites to determine whether they are
direct targets of the Ldb1 complex. Supplemental Figure 8
Figure 2. Differences in transcription factor complex composition at selected loci. The number of overlapping sequence reads
originating from the different ChIP-seq experiments were plotted relative to chromosomal position using Solex (red bars). Signals obtained
from the control ChIP-seq experiment are also shown (green bars). Chromosomal positions as well as sequence conservation (mammalian
cons.) are indicated above and below ChIP-seq plots, respectively. The figure shows clustering of all five transcription factors at theGata1
hematopoietic enhancer (left panel), Ldb1 complex without Eto2 at the Cdh23 locus (middle panel), and Eto2 complex without Ldb1 at
the Casp12 gene promoter (right panel).
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shows the example of the top 25 up-regulated or down-
regulated genes and the target binding sites of the complex
within 100 kb of the transcription start site (TSS). It is
clear that most of these up-regulated genes are direct
targets of the complex (84% have at least one strong Ldb1
complex-binding site within 50 kb of the TSS). On the
other hand, most of the 25 most strongly down-regulated
genes (72%) show no evidence of binding of the Ldb1/
Tal1/Gata1 complex, although there are exceptions (Sup-
plemental Fig. 8). Including the top 50 up-regulated and
down-regulated genes shows even more dramatic differ-
ences, with 96% of the up-regulated genes having binding
of the complex versus only 20% for the down-regulated
ones, with up-regulated ones typically sporting stronger
Figure 3. Dynamics of the Ldb1 complex components during the course of erythroid differentiation. ChIP-seq data showing binding of
Ldb1, Tal1, Gata1, Eto2, and Mtgr1 to the Gypa, Epb4.2, Alas2, and Slc22a4 genes. (A–D) Binding profiles before (uninduced) and after
(induced) differentiation. (E) ChIP analysis on nontransfected MEL cells showing enrichments of endogenous factors before (uninduced)
and after (induced) differentiation. Data are represented as mean 6 SEM. (F) Ratios of Ldb1 and Tal1 enrichments over Eto2 showing
increases of Ldb1 and/or Tal1 after differentiation (ratios before differentiation are set to 1).
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binding and greater proximity to the TSS (data not shown).
Further analysis of these data by separating the binding
sites of all the genes that were significantly up-regulated
or down-regulated (P < 0.001) showed that the strong
binding sites and the vast majority of binding sites of the
Ldb1 complex are on up-regulated genes, but not down-
regulated genes (P = 0, x2 test) (Fig. 5A,B; Supplemental
Fig. 8): Indeed, the significantly down-regulated genes are
largely devoid of either Ldb1 or Tal1 binding. In contrast,
Gata1 (which is also part of a number of repressive
complexes) (Hong et al. 2005; Rodriguez et al. 2005)
or a subcomplex of Gata1 with Ldb1 (lacking Tal1 and
Eto2/Mtgr1) also shows frequent binding to the regulatory
regions of repressed genes (Fig. 5B). Thus, the Ldb1
complexes can be subdivided into two main entities: an
Ldb1/Gata1/Tal1/Eto2/Mtgr1-activating complex, and an
Ldb1/Gata1 with both activating and repressing activities
(Fig. 5B; Supplemental Fig. 8).
The analysis also showed that the Ldb1 complex binds
in different positions relative to the TSS of the gene, from
the proximal promoter region to tens of kilobases away. In
a number of recent studies, we and others investigated
differences in responsiveness to long-range regulation be-
tween different classes of core promoters (Engstrom et al.
2007; Megraw et al. 2009). We therefore also asked the
following questions: (1) Where are the binding sites
located primarily relative to the TSS? (2) Are there any
differences in their distribution between genes with
different types of core promoters? Although there were
strong complex-binding sites in ‘‘textbook positions’’ up-
stream of the gene, the highest frequency of sites was
found to map to the first intron of genes (Fig. 5C). How-
ever, when we classified the corresponding promoters
into the CpG and non-CpG classes, a striking difference
emerged: The Ldb1 complex-binding sites in proximal
promoters of regulatory genes were found almost exclu-
sively in non-CpG island promoters (red bubbles in Fig.
5D; Supplemental Fig. 9). Non-CpG promoters show an
overrepresentation of TATA boxes and are associated
predominantly with specific expression in terminally
differentiated tissues (Carninci et al. 2006). On the other
hand, the up-regulated genes with CpG promoters (green
bubbles in Fig. 5D) showed Ldb1 complex binding pre-
dominantly downstream from the promoter, most in their
first intron (Fig. 5C,D; Supplemental Figs. 8, 9). CpG island
promotersmost often lack TATA boxes, and are associated
with either housekeeping genes or developmentally regu-
lated genes. In our recent study (Akalin et al. 2009),
a subset of CpG island promoters was shown to be the
type that is most responsive to long-range regulation. It is
interesting, however, that many of the most up-regulated
Figure 4. Hierarchical clustering of normalized expression
levels. The figure summarizes the average of normalized expres-
sion levels of gene-specific probes (annotated with the same gene
name after normalization) of all samples under study. Genes that
showed a significant difference (P-value of Student’s t-test, <0.05)
were selected. Genes with no annotation were removed, and the
100 most up-regulated and down-regulated genes were biclus-
tered (euclidean distance, average linkage). The resulting heat
map of absolute log2-transformed expression levels for unin-
duced and induced samples is shown. The color coding is a
double gradient, where the high-end genes are shown in red and
the low-end genes are shown in green.
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Figure 5. Bubble plot representation of transcription factor-binding sites around differentially regulated genes. The bubble plots
encode up to four quantitative parameters per one ChIP signal: distance from the promoter of a gene (X-axis), log2 of fold change in
expression of that gene between the induced and uninduced states (Y-axis), the intensity of the binding signal/peak (bubble diameter),
and, optionally, different categorical information (bubble color) (A) Bubble plots showing peak size and distance to promoter of the
closest gene and fold change of that gene between MEL-induced and uninduced cells. Only significantly differentially expressed genes
are shown. There is a clear bias for the elements of the complex to associate with genes up-regulated upon induction (P ; 0, Wilcoxon
test). (B) Plot for Gata1 split by the co-occurrence with other factors at the same location. The Ldb1 complex associates with up-
regulated genes, while Gata1/Ldb1 without Tal1 and Eto2/Mtgr1 clusters close to promoters of both up-regulated and down-regulated
genes. (C) Same as A, colored by the region of/around the reference gene. The first exon and first intron are marked separately from the
rest of the internal introns and exons—the former since it is often part of the promoter, and the latter to show that it is a preferred
binding region. (D) Same as A, with bubbles/peaks colored by the promoter type of the associated genes. The distribution shows that
the non-CpG promoters of up-regulated genes have clear preference for complex binding close to the TSS, and that CpG island
promoters respond to regulation from larger distances, most often from the first intron.
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genes often showmore than one strong binding site for the
Ldb1 complex (Supplemental Fig. 8). The significance of
these multiple sites is unknown at present.
Binding sites in large intergenic regions
In the plots shown in Figure 5, the binding sites are with-
in a relatively short distance from the genes, and the
relevant gene can be identified easily. However, there is
a class of binding sites that are located in areas that are
totally devoid of genes for hundreds of kilobases. Figure 6
shows two such cases. The first is a binding site that is
present in an area of chromosome 16without any (known)
genes within a few hundred kilobases. The closest gene,
AK007854, is >150 kb away, but this is unlikely to be
a target gene, as we could not detect up-regulation upon
differentiation (data not shown). The closest gene that is
up-regulated in the differentiated cells is Runx1 (log fold
change 0.77; P = 0.005) situated 300 kb away from the
binding sites. Interestingly, these binding sites are the
only sites within 250 kb of DNA. Both sites have never
Figure 6. Binding sites in large intergenic regions. The top panel shows two binding sites at ;300 kb upstream of the Runx1 gene in
a gene-poor region. The bottom panel shows two binding sites at ;210 kb from the Klf3 gene. The binding profiles of the different
transcription factors in uninduced and induced MEL cells are shown.
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beenmapped before as regulatory sites of the Runx1 gene,
and both show a relative decrease of Eto2 and Mtgr1
consistent with up-regulation. The second example is
similar: The site is several hundred kilobases away from
the closest up-regulated gene, Klf3, whereas a number of
other genes are much closer to the binding site. Klf3 is
an antagonist of Klf1 activated by the same Klf1, a late
erythroid activator that is required for the activation of
many erythroid genes during the last steps of differentia-
tion. Klf3 is a developmental regulatory gene that is itself
regulated by long-range interactions in what is known
a genomic regulatory block (GRB) (Kikuta et al. 2007).
GRB target genes are often flanked by large intergenic
regions spanned by highly conserved and other noncoding
elements that act as long-range enhancers (Sandelin et al.
2004; Pennacchio et al. 2006; Kikuta et al. 2007). Other
large intergenic regions with Ldb1 complex-binding sites
are found around genes such as Ets2,Max,Mef2c, or Pim1,
all known to be involved in the regulation of hematopoi-
esis. These and similar data for many other genes (data not
shown) suggest that the Ldb1 complex is involved in long-
range interactions. We therefore tested this possibility
for chromosome 7 (see below), which has been analyzed
previously by Chromosome Conformation Capture-on-
Chip (4C) (Simonis et al. 2006).
Interactions between regulatory regions
The Ldb1 complex is thought to be important for long-
range interactions. It was clear from the ChIP-seq data
that most binding sites of the Ldb1 complex were with
up-regulated genes (see above), and that the data identi-
fied a number of regions that are thought to interact with
each other. The best-documented example is the b-globin
locus. The hypersensitive sites 1–4 (HS1–4) of the LCR of
the b-globin locus all bind the Ldb1 complex before
differentiation (Fig. 7), and the level of binding to HS2–4
increases upon differentiation when the b-globin gene is
expressed at high levels. We therefore carried out a Chro-
mosome Conformation Capture sequencing (3C-seq) ex-
periment focusing on chromosome 7, using the b-globin
gene (b-major promoter) as the viewpoint to determine
whether binding sites of the Ldb1 complex would iden-
tify long-range interactions between genes and regulatory
regions. In this experiment, 12.5-dpc fetal liver and fetal
brain tissues were used, and interacting sequences were
identified as HindIII fragments using Illumina paired-end
sequencing. Peaks on a genomic location were considered
to be fetal liver-specific when the 3C-seq read counts in
the fetal brain samples were <10% of the sequence reads
in the fetal liver samples. The interacting sequences were
Figure 7. Long-range interactions between ldb1 complex-bound regulatory regions. A selection of long-range interactions between the
Ldb1 complex-bound b-major promoter and other ldb1-bound regulatory regions identified in 12.5-dpc fetal livers. Coordinates in
megabases (Mb) on chromosome 7 are indicated at the top of each panel. The sum of the 3C sequence reads are indicated in blue. The
HindIII fragments analyzed by 3C sequencing are indicated by light-gray bars. The sum of the ChIP-seq reads for Ldb1 are indicated in
green; induced C88 MEL cells are on top, and uninduced C88 MEL cells are below. Genes are indicated by black bars, while the log fold
change in gene expression between uniduced and induced C88 MEL cells is indicated in gray. (A) Long-range interactions between the
b-major promoter and the b-globin LCR (mainly HS2 and HS4). The red bars indicate the approximate position of hypersensitive sites.
(B,C) 3C-seq identifies the known long-range interactions between the b-major promoter and the Uros gene (B) and Kcnq1 region (more
specifically, Tspan32) (C). Both genes are bound by the Ldb1 complex. (D) A previously unknown long-range interaction between the
b-major promoter and the Suv420h2 gene is identified, which correlates with Ldb1 binding.
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subsequently compared with the Ldb1-binding sites be-
fore and after differentiation. The results coincide with
detection of the ldb1 complex at the promoter of the
b-globin gene (Fig. 7A) and the presence of an interaction
signal between the LCR and the promoter, in line with
previous data (Tolhuis et al. 2002; Palstra et al. 2003; Song
et al. 2007). This suggests that the Ldb1 complex forms
loops within larger loops that are mediated by other
factors, such CTCF/cohesin (Splinter et al. 2006; S Krpic,
M Eijpe, and F Grosveld, unpubl.). Other interactions of
the b-major promoter with up-regulated genes are also
visible; for example, the known interaction with Uros
(Osborne et al. 2004; Simonis et al. 2006). It shows one
binding site of the Ldb1 complex before differentiation
and an additional site after differentiation that are
matched by interactions seen by 3C-seq (Fig. 7B). In-
terestingly, the resolution of these interactions is very
defined as opposed to a broad peak of interactions by
regular 4C (Simonis et al. 2006). For example, the known
interaction in the region of the Kcnq1 gene maps specif-
ically to the Tspan32 gene. It shows binding before dif-
ferentiation that increases after differentiation and is
matched by interactions on the same HindIII fragment
(Fig. 7C). New interactions are also detected. For example,
the Suv420h2 gene shows a specific interaction peak that
coincides with its binding site for the Ldb1 complex.
Interestingly, in addition to Suv420h2, its neighboring




Here we determined and analyzed the genome-wide
binding sites of the Ldb1 complex (Wadman et al. 1997;
Meier et al. 2006) before and after differentiation of MEL
cells—a model system for the differentiation of proeryth-
roblast cells to fully differentiated hemoglobinised cells.
The binding sites were matched with the gene expression
profiles before and after differentiation to determine the
target genes of the complex during differentiation. The
binding sites were obtained by using a tagging approach,
with the biotin tag generally yielding the best results.
The precipitate can be washed more stringently due to
the high-affinity binding, resulting in lower background
signals. The use of antibodies directed against a partic-
ular transcription factor usually results in a much lower
signal-to-background ratio, and such antibodies were used
only to confirm that the nontagged endogenous factor
binds the same sequence as found with the tagged factor
(e.g., see Fig. 3). The resolution and sequence coverage of
the experiment enables practically certain identification
of thousands of binding sites (Supplemental Figs. 2B, 3),
and further increases in sequencing power and the de-
velopment of more advanced error models and processing
algorithms are likely to push the confidence limits much
further very soon. The very highmapping scores at a small
number of genomic locations are easily filtered out us-
ing the control experiments. They can be recognized (or
filtered out) in the Solex program or the nascent Biocon-
ductor (http://www.bioconductor.org) pipeline as perfect
blocks of sequences rather than a distribution of se-
quences around a recognition site. It is also apparent from
the data that it is not easy to standardize the sequence
results and compare them across the different factors.
Clearly, a factor like Eto2 that does not bindDNA directly
but is only bound to a DNA-binding factor via bridging
proteins such as Ldb1 is less efficiently cross-linked to
DNA with formaldehyde, and reproducibly has a lower
signal-to-background ratio than a factor like Gata1 or Tal1
that binds DNA directly and is cross-linked more effi-
ciently. Thus, greater sequencing depth is required to ob-
tain the same level of confidence for Eto2 than is needed
for Gata1 or Tal1. Finally, it should be noted that none of
the methods—i.e., tagging the 59 or 39 end or using anti-
bodies directly—will guarantee detecting all of the binding
sites. All may bring about structural changes in the com-
plex or not be freely accessible at all sites.
Ldb1 complexes and associated binding sites
A number of different complexes have been identified for
Gata1 (Rodriguez et al. 2005), and a number of subcom-
plexes have been identified for Ldb1 in erythroid cells
(Meier et al. 2006). Both of these observations made by
transcription factor pull-downs and mass spectrometry
are confirmed by the ChIP-seq data (e.g., see Figs. 2, 5).
Most importantly, the Ldb1 complex changes during dif-
ferentiation; in particular, the relative level of the nega-
tive regulators Eto2/Mtgr1 is decreased (Meier et al.
2006). This is confirmed by the decrease of Eto2 binding
in the ChIP-seq (Fig. 1; Supplemental Fig. 2), and suggests
that the full complex containing Eto2/Mtgr1 is bound to
genes that are poised to be expressed during the last steps
of differentiation. This is indeed observed when the
binding site analysis is combined with the gene expres-
sion analysis, which shows that the vast majority of the
genes are up-regulated by the Ldb1 complex, many of
which are related to heme synthesis and red cell mem-
brane structure. At present, it is not clear how the com-
plex activates gene expression, but it is very likely that at
least part of the effect is mediated through its binding of
Cdk9 before differentiation and is largely lost during
differentiation (Meier et al. 2006). A recent study has
shown that Cdk9 binds the entire mediator complex
(C Bezstarosty, A Ghamari, F Grosveld, and J Demmers,
in prep.), which may be an intermediate step before Cdk9
phosphorylates the Ser2 residue of the C-terminal do-
main (CTD) tail of RNA polymerase II, and thus allows
transcriptional elongation through the gene. Thus, one of
the main functions of the Ldb1 complex may be the
‘‘delivery’’ of Cdk9 to the basic transcription machinery,
which would fit well with the results described for the
function of the LCR in the b-globin locus (Sawado et al.
2003; see below).
The peaks of the binding activities directly identify the
DNA-binding motif, which in the case of the full complex
is near enough to the published sequence for the Gata1-
bindingmotif, but very different for the E-boxmotif bound
Soler et al.
286 GENES & DEVELOPMENT
by Tal1. It shows a specific motif, (C)TGN7–8WGATAR, or
a C(A/T)GCTG motif different from the published E-box
sequence (CANNTG). In contrast, Gata1 also binds many
negatively regulated genes, and these do not show the
E-box motif. It is also worth noting that many binding
sites occur asmultiple binding sites (Supplemental Figs. 6,
7); presumably, this increases the efficiency of binding the
complex, although it is equally possible that this allows
interactions with more than one distant regulatory site at
the same time (see below).
The analysis of the position of the binding sites is even
more interesting. First, the complex binds most often
downstream from the TSS, and is very frequently found in
the first intron of a gene (Fig. 5). Second, there is a clear
difference in the binding pattern of the Ldb1 complex to
CpG-rich promoters, as found in the majority of genes
and non-CpG promoters that encompass TATA-box pro-
moters. In CpG promoters, most commonly the binding
sites are found between 1 and 3 kb downstream from the
TSS, whereas in the non-CpG and/or TATA-box-containing
promoters, most binding sites are found in the pro-
moter, with the exception of the Gata1-binding sites,
which show a second peak downstream from the TSS.
The latter belong to other Gata1 complexes (E deBoer,
C Andrieu-Soler, E Soler, JC Bryne, S Thongjuea, M
Stevens, C Kockx, Z Ozgur, W van IJcken, B Lenhard
et al., in prep.). Since it has been reported that transcription
of TATA-less genes is independent of Cdk9 (Montanuy
et al. 2008), we compared the sensitivity of each category
of promoters to Cdk9 inhibition by 5,6-dichloro-1-b-d-
ribofuranosylbenzimidazole (DRB). This showed both
CG-rich and non-CG-rich promoters to be sensitive to
DRB, and only amodest difference in the average response
of the CG (39% of normal) and non-CG (30% of normal)
promoters was observed (data not shown). Similarly, when
TATA-box-containing promoters versus non-TATA-box
promoters were compared, the values were 40% and 34%,
respectively. We conclude that both types of promoters
are dependent on cdk9, and that the dependency is very
similar for the different type of promoters.
The Ldb1 complex and long-range interactions
Ldb1 was originally described as a factor as important for
long-range interactions in Drosophila as Chip (Morcillo
et al. 1997), a protein that can interact with the insulator
protein Su(Hw) (Torigoi et al. 2000). It was subsequently
shown to be involved in at least one long-range interac-
tion in erythroid cells—namely, between the LCR and the
b-globin gene (Song et al. 2007)—by showing that Ldb1
can be detected at the b-globin promoter after differenti-
ation in the absence of a binding site of the Ldb1 complex
in the promoter of the b-globin gene, although it should
be noted that, in the human b-globin cluster, loops are
still formed between the LCR and the b-globin gene in the
absence of the promoter, suggesting that additional se-
quences and interactions are important (Patrinos et al.
2004). The Chip-seq data show that binding sites of the
Ldb1 complex are often at long distances from a gene that
it (possibly) up-regulates (Fig. 6). When the ChIP-seq data
are combined with 3C-seq data focusing on chromosome
7 that contains the b-globin locus, it is evident that the
Ldb1 complex binds to the HS2,3 and HS4 of the LCR;
this binding appears to increase upon differentiation, and
is accompanied by the appearance of binding of the Ldb1
complex at the b-globin gene (Hbb-b1) (Fig. 7). This con-
firms the published data (Song et al. 2007), and suggests,
in combination with our previous data on the interac-
tions within the locus (Palstra et al. 2003), that large loops
are formed independently of the Ldb1 complex before
differentiation that does not involve part of the LCR (HS2
and HS3), but that loops are formed within these loops
dependent on the Ldb1 complex. It is presently not clear
which biochemical property of the complex is involved
in this process—most likely at least its dimerization
domain—but it is less clear why this would only be the
case after differentiation, and which change in the com-
plex (or another interacting molecule[s]) is responsible for
loop formation. Interestingly, further analysis of a number
of known and novel interactions on chromosome 7 using
the b-globin gene as the viewpoint suggest that the Ldb1
complex may be important for the interactions taking
place between different loci on the same chromosome.
Although it does not constitute definitive proof, we there-
fore analyzedwhether the number of Ldb1-binding sites in
HindIII fragments interacting with the b-globin promoter
is higher thanwould be expected on a randombasis. There
are 910 positive HindIII fragments on chromosome 7,
covering 3.6 Mb (2.36%) of the total chromosome length
of 153 Mb. Assuming that Ldb1 binds randomly, this
wouldmean that a random location on chromosome 7 has
a 2.36% chance of being in a HindIII fragment that in-
teracts with the b-globin promoter. There are 272 signif-
icant Ldb1-binding sites on chromosome 7. Any random
272 locations would have 6.42 locations that overlap with
a HindIII fragment interacting with the b-globin promoter
(2.36%3 272). We observe 31 such Ldb1 sites and 241 that
do not interact. The probability of finding 31 versus the
randomly expected 6.42 is 5.3 3 e13 (Poisson distribu-
tion), and hence is highly significant.
At present, it is not clear what the significance of these
interactions is within a living cell, as they are of a com-
pletely different scale than the interactions seen within
a locus and take place at a much lower frequency, as dem-
onstrated by the different scales in Figure 7. Clearly, the
interactionswithin a locus are of crucial importance for the
proper activation of genes, and it is clear that the Ldb1
complex plays a primary role in this interaction process.
Materials and methods
Plasmid construction
Expression vectors for bacterial biotin ligase BirA and bio tagging
were as described (de Boer et al. 2003). Bio-tagged Ldb1 was as
described (Meier et al. 2006). V5-Bio or V5-Flag-Bio constructs
(Kolodziej et al. 2009; Soler et al. 2009) were used to tag Eto2,
Mtgr1, and Gata1 cDNA at the C-terminal end of the protein. All
constructs were verified by DNA sequencing and transfected into
MEL cells to obtain stable clones expressing the tagged protein.
Only clones expressing the tagged protein at low levels (<50%
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increase in expression) were used for analysis, and all of these
showed the normal induction of erythroid terminal differentiation.
Cell culture
MEL cell lines were maintained in DMEM supplemented with
10% fetal calf serum and penicillin/streptomycin. MEL cells in
the log phase of growth were induced to differentiate with 2%
dimethylsulfoxide (DMSO) for 4 d.
ChIP and ChIP-seq assays
Preparation of cross-linked chromatin for ChIP and ChIP-seq
(13 107 cells per ChIP; 13 108 cells per ChIP-seq), sonication to
200–800-base-pair (bp) fragments, immunoprecipitations, and
DNA purification were as described (Rodriguez et al. 2005;
Kolodziej et al. 2009; Soler et al. 2009). Detailed materials and
methods are described in the Supplemental Material.
Microarray and statistical analysis
The GeneChip Mouse Gene 1.0 ST array oligonucleotide micro-
array (Affymetrix) was used. Detailed materials andmethods and
statistical analysis are described in the Supplemental Material.
3C sequencing
The 3C librarywas prepared as described previously (Simonis et al.
2006). The library was sequenced using the Illumina paired-end
protocol, and data were visualized using Signal map (Nimblegen)
(see the Supplemental Material).
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